Medicine and HealthNature Microbiology
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
B. J. Willett, J. Grove, et al.
This groundbreaking research showcases how the Omicron variants BA.1 and BA.2 of SARS-CoV-2 are able to evade neutralization from vaccines, with significant implications for public health. Conducted by a team of experts, this study reveals the underlying mechanisms of these variants' pathogenicity, highlighting a crucial evolution in our fight against COVID-19.
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Medicine and Health
Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection
Y. Guo, G. Zhang, et al.
Medicine and Health
Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants
C. Sun, Y. Kang, et al.
Biology
SARS-CoV-2 variant biology: immune escape, transmission and fitness
A. M. Carabelli, T. P. Peacock, et al.
Medicine and Health
Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda
D. L. Bugembe, M. V. T. Phan, et al.
